Reporting of sex-specific outcomes in trials of interventions for cardiovascular disease: has there been progress?

All patients, women and men, expect medication to be both safe and effective. Women and men not only differ biologically ( “sex”) but also socio-cultural and behavioral differences exist (“gender”). As both sex and gender influence the safety and efficacy of medication, it is important that prior to approval of a drug, a sufficient number of (representative) women are included in preregistration phase 1 to 3 tri als.

Source: Maturitas - September 27, 2020 Category: Primary Care Authors: M.M. Schreuder, E. Boersma, M. Kavousi, L.E. Visser, J.W. Roos - Hesselink, J. Versmissen, J.E. Roeters van Lennep Source Type: research